# Upstream Bio, Inc.: Form 8-K, filed Oct 15, 2024

- Company: [Upstream Bio, Inc.](/companies/upb.md) (CIK 2022626)
- Form: 8-K
- Filed: 2024-10-15
- Accepted by EDGAR: Oct 15, 2024, 16:05 ET
- Period: 2024-10-10
- Accession: 0001193125-24-237580
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2022626/000119312524237580/d897785d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2022626/000119312524237580/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2022626/000119312524237580/d897785d8k.htm

Filed Oct 15, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-237580. Last ingested by Listed: Nov 10, 2026, 16:50 ET. No prices; not investment advice.